Cargando…
Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance
BACKGROUND: Standard treatment for severe malaria is with artesunate; patient survival in the 24 hours immediately posttreatment is the key objective. Clinical trials use clearance rates of circulating parasites as their clinical outcome, but the pathology of severe malaria is attributed primarily t...
Autores principales: | Jones, Sam, Hodel, Eva Maria, Sharma, Raman, Kay, Katherine, Hastings, Ian M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452316/ https://www.ncbi.nlm.nih.gov/pubmed/30517708 http://dx.doi.org/10.1093/infdis/jiy649 |
Ejemplares similares
-
Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria
por: Intharabut, Benjamas, et al.
Publicado: (2019) -
Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study
por: Ataíde, Ricardo, et al.
Publicado: (2017) -
An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies
por: Staehli Hodel, Eva Maria, et al.
Publicado: (2012) -
The threat of artemisinin resistant malaria in Southeast Asia
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016) -
Should Deep-Sequenced Amplicons Become the New Gold Standard for Analyzing Malaria Drug Clinical Trials?
por: Jones, Sam, et al.
Publicado: (2021)